Article Information
History
- February 26, 2021.
Article Versions
- Version 1 (January 8, 2021 - 04:24).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Seyed M. Moghadas, PhD1,
- Meagan C. Fitzpatrick, PhD2,3,
- Affan Shoukat, PhD3,
- Kevin Zhang, MD(c)4 and
- Alison P. Galvani, PhD3,*
- 1Agent-Based Modelling Laboratory, York University, Toronto, Ontario, M3J 1P3 Canada
- 2Center for Vaccine Development and Global Health, University of Maryland School of Medicine, 685 W Baltimore St, Baltimore, MD 21201
- 3Center for Infectious Disease Modeling and Analysis (CIDMA), Yale School of Public Health, New Haven, Connecticut, USA
- 4Faculty of Medicine, University of Toronto, Toronto, Ontario, M5S 1A8 Canada
- ↵*Corresponding author:
Alison P. Galvani, Center for Infectious Disease Modeling and Analysis (CIDMA), Yale School of Public Health, New Haven, Connecticut, USA, Telephone: Email: alison.galvani{at}yale.edu